Dear Sir, Endothelial dysfunction (ED), characterized by an imbalance between relaxing and contracting factors, procoagulant and anticoagulant substances, and between proinflammatory mediators, may play a particulary significant role in the pathogenesis of atherosclerosis.
1
Under physiological conditions, the vascular endothelium produces many substances that are closely involved in haemostasis, fibrinolysis, growth factor synthesis, and the regulation of vessel tone and permeability. One of these substances is von Willebrand factor (vWf), which is synthesized by and stored in endothelial cells. VWf is a multimeric glycoprotein, and it is essential for platelet aggregation and adhesion. 2 Numerous clinical and experimental reports suggest that high vWf level reflects endothelial damage or ED. VWf levels have been proposed as an indicator of ED. 3 White-coat hypertension (WCHT) is a condition in which patients have high clinical blood pressure (CBP), but it is ambulatorily normal. The risk profile of WCHT has not yet been completely clear, and it is not known whether it represents a separate clinical entity, a prehypertensive state, or a low-risk stratum of essential hypertension. 4 Some studies have shown that WCHT represents a low-risk group, whereas others have not.
There are several studies in which ED was demonstrated in patients with essential hypertension. 5 However, there are limited number of studies about ED in patients with WCHT. In this study, we evaluated ED by measuring plasma vWf levels in patients with WCHT.
Age-, sex-, and body mass index (BMI)-matched 15 normal subjects, 15 patients with WCHT, and 15 patients with sustained hypertension were included in the study. The clinical characteristics of each subject are shown in Table 1 . Patients who had a history of antihypertensive drug intake, smoking, diabetes mellitus (fasting glucose 4126 mg/dl or haemoglobin A 1c 46.2%), obesity (BMIX30 kg/m 2 ), cerebrovascular disease, ischaemic heart disease, congestive heart failure, malignancy, and chronic renal failure (serum creatinine 41.5 mg/dl, blood urea nitrogen 430 mg/dl) were excluded from the study. Sustained hypertension was defined as systolic BPX140 mmHg and/or diastolic BPX90 mmHg in-clinic and daytime ambulatory. In this study, WCHT was defined as a difference between CBP and ambulatory blood pressure (ABP) of at least 20 mmHg for systolic BP and/or 10 mmHg for diastolic BP. All patients gave their informed consent to participate in the study.
CBP measurements were performed in our outpatients unit by a standard mercury sphygmomanometer after 10 min resting. BP values were determined by the mean value of three consecutive measurements with 2-min intervals. Then all subjects were fitted with an ABP monitor for 24 h. A portable noninvasive recorder (SpaceLabs Medical Devices, Inc., Redmond, WA, USA) was used in all studies and was programmed to record blood pressure every 30 min for 24 h. This information was used to calculate the average ABP for each patient over a 24-h period. Plasma vWf levels were measured quantitatively by STA-LIATEST (Diagnostica Stago (France)). All of the samples were measured at the same run.
Statistical analysis was performed using KruskalWallis and Spearman's correlation tests. Po0.05 was accepted as statistically significant. The values were given as median, minimum, and maximum.
Clinical SBP and DBP were higher in all three occasions in patients with sustained and WCHT than in normal subjects (Po0.001). In contrast, the ABP (systolic and diastolic) for the 24-h period did not differ between WCHT patients and normal subjects (P40.05). Plasma vWf levels of study groups are shown in Table 1 . The plasma levels of vWf were significantly higher in patients with sustained and WCHT than in normotensive group (Po0.001). There were not any differences in plasma levels of vWf between sustained and WCHT groups (P40.05). The levels of vWf were related to diastolic BP in sustained hypertension and WCHT groups (Po0.05).
It has been previously shown that increased vWF plasma levels reflect ED and may also have prognostic value in patients with atherosclerotic disease. 6 In our study, patients with clinically overt cardiovascular disease (such as coronary artery disease, cerebrovascular disease and renal failure) were excluded to clarify the specific hypertensionrelated abnormalities of endothelial damage and/or ED.
In the presence of essential hypertension, defective endothelium-dependent vasodilatation and increased sensitivity to vasoconstrictors may increase vascular resistance. 1 The significantly increased plasma vWf levels in patients with hypertension were demonstrated in several studies; 7 however, there is only one study in which plasma vWf levels were measured in elderly patients with WCHT, and no difference was found between WCHT and normotensive control subjects. 8 In contrast to this study, we found that the levels of vWf were significantly higher in WCHT patients than in the control group.
The BP of patients with WCHT measured in the doctor's office is higher than measurements obtained from ABP monitoring. There is no consensus about its clinical importance and therapy requirement. 9 WCHT is a benign condition according to some researchers. On the other hand, some investigators have suggested that WCHT is not a benign condition. Our data suggest that WCHT subjects without other cardiovascular risk factors revealed ED and/or endothelial damage, and WCHT in adults may not be an innocent phenomenon, probably WCHT may progress to essential hypertension. 
